For COL5A1 (Figure 3D), high expression is linked to increased risk in liver hepatocellular carcinoma (LIHC) and lung adenocarcinoma (LUAD) but offers protective benefits for KIRC, demonstrating its dual nature in cancer prognosis. This evidence concerns the gene COL5A1 and cancer.